| # | Drug | Count |
|---|---|---|
| 0 | UPADACITINIB | 16 |
| 1 | ADALIMUMAB | 8 |
| 2 | ASPIRIN | 5 |
| 3 | ASPIRIN 325 MG | 5 |
| 4 | ASPIRIN 81 MG | 5 |
| 5 | METHOTREXATE | 5 |
| 6 | METHOTREXATE SODIUM | 5 |
| 7 | PANTOPRAZOLE | 5 |
| 8 | ESOMEPRAZOLE MAGNESIUM | 4 |
| 9 | IBRUTINIB | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDROCORTISONE VALERATE | 1 | 0.0016 |
| 1 | HYALURONIC ACID | 1 | 0.0009 |
| 2 | HYALURONATE SODIUM | 1 | 0.0007 |
| 3 | PRALSETINIB | 1 | 0.0005 |
| 4 | OSILODROSTAT | 1 | 0.0005 |
| 5 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | 1 | 0.0004 |
| 6 | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | 1 | 0.0004 |
| 7 | PYRIDOXINE HYDROCHLORIDE | 1 | 0.0004 |
| 8 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0003 |
| 9 | AMIVANTAMAB-VMJW | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 3 | 0.0014 |
| 1 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0005 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 3 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 4 | Human Immunoglobulin G [EPC] | 3 | 0.0001 |
| 5 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 6 | Janus Kinase Inhibitor [EPC] | 16 | 0.0001 |
| 7 | Antimalarial [EPC] | 1 | 0.0001 |
| 8 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 9 | Barbiturate [EPC] | 1 | 0.0001 |